 |
12 Diseases |  |
4 Trials |
|
4 Trials |  |
232 News |  |
| «1234 |
- ||||| Trumenba (meningococcal B vaccine) / Pfizer
Trial initiation date: A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. (clinicaltrials.gov) - Sep 16, 2012
P3, N=3300, Recruiting, Sponsor: Pfizer
Initiation date: Jul 2012 --> May 2013
- | Trumenba (meningococcal B vaccine) / Pfizer
Trial completion: Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults (clinicaltrials.gov) - Aug 27, 2012
P1, N=48, Completed, Sponsor: Pfizer
Initiation date: Jul 2012 --> May 2013 Active, not recruiting --> Completed
- ||||| Trumenba (meningococcal B vaccine) / Pfizer
New P2 trial: A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 (clinicaltrials.gov) - Oct 26, 2011
P2, N=2519, Completed, Sponsor: Pfizer
- ||||| Trumenba (meningococcal B vaccine) / Pfizer
New P2 trial: A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age (clinicaltrials.gov) - Oct 26, 2011
P2, N=2625, Active, not recruiting, Sponsor: Pfizer